Nova Financial’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
Nova Financial's TVRD Position: Q3 2026 in Review
Nova Financial opened a new position in Tvardi Therapeutics (TVRD) in Q3 2026: 8 shares worth $10. The stake represents ﹤0.01% of the portfolio and ranks #862 among its holdings.
61 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.
- Nova Financial held 8 shares of Tvardi Therapeutics worth $10 as of Q3 2026.
- Tvardi Therapeutics was a new Nova Financial position in Q3 2026.
- Tvardi Therapeutics made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #862 holding.
- 61 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.
Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.